179 related articles for article (PubMed ID: 37606993)
1. MSDRP: a deep learning model based on multisource data for predicting drug response.
Zhao H; Zhang X; Zhao Q; Li Y; Wang J
Bioinformatics; 2023 Sep; 39(9):. PubMed ID: 37606993
[TBL] [Abstract][Full Text] [Related]
2. Modular within and between score for drug response prediction in cancer cell lines.
Wang S; Li J
Mol Omics; 2020 Feb; 16(1):31-38. PubMed ID: 31802092
[TBL] [Abstract][Full Text] [Related]
3. A similarity-based deep learning approach for determining the frequencies of drug side effects.
Zhao H; Wang S; Zheng K; Zhao Q; Zhu F; Wang J
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34718402
[TBL] [Abstract][Full Text] [Related]
4. Prediction of anticancer drug sensitivity using an interpretable model guided by deep learning.
Pang W; Chen M; Qin Y
BMC Bioinformatics; 2024 May; 25(1):182. PubMed ID: 38724920
[TBL] [Abstract][Full Text] [Related]
5. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.
Peng W; Liu H; Dai W; Yu N; Wang J
Bioinformatics; 2022 Sep; 38(19):4546-4553. PubMed ID: 35997568
[TBL] [Abstract][Full Text] [Related]
6. A novel graph attention model for predicting frequencies of drug-side effects from multi-view data.
Zhao H; Zheng K; Li Y; Wang J
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34213525
[TBL] [Abstract][Full Text] [Related]
7. A multimodal deep learning framework for predicting drug-drug interaction events.
Deng Y; Xu X; Qiu Y; Xia J; Zhang W; Liu S
Bioinformatics; 2020 Aug; 36(15):4316-4322. PubMed ID: 32407508
[TBL] [Abstract][Full Text] [Related]
8. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
9. MultiDTI: drug-target interaction prediction based on multi-modal representation learning to bridge the gap between new chemical entities and known heterogeneous network.
Zhou D; Xu Z; Li W; Xie X; Peng S
Bioinformatics; 2021 Dec; 37(23):4485-4492. PubMed ID: 34180970
[TBL] [Abstract][Full Text] [Related]
10. Predicting synergistic anticancer drug combination based on low-rank global attention mechanism and bilinear predictor.
Gan Y; Huang X; Guo W; Yan C; Zou G
Bioinformatics; 2023 Oct; 39(10):. PubMed ID: 37812255
[TBL] [Abstract][Full Text] [Related]
11. Deep mining heterogeneous networks of biomedical linked data to predict novel drug-target associations.
Zong N; Kim H; Ngo V; Harismendy O
Bioinformatics; 2017 Aug; 33(15):2337-2344. PubMed ID: 28430977
[TBL] [Abstract][Full Text] [Related]
12. A novel approach for drug response prediction in cancer cell lines via network representation learning.
Yang J; Li A; Li Y; Guo X; Wang M
Bioinformatics; 2019 May; 35(9):1527-1535. PubMed ID: 30304378
[TBL] [Abstract][Full Text] [Related]
13. Inverse similarity and reliable negative samples for drug side-effect prediction.
Zheng Y; Peng H; Ghosh S; Lan C; Li J
BMC Bioinformatics; 2019 Feb; 19(Suppl 13):554. PubMed ID: 30717666
[TBL] [Abstract][Full Text] [Related]
14. Drug repositioning through integration of prior knowledge and projections of drugs and diseases.
Xuan P; Cao Y; Zhang T; Wang X; Pan S; Shen T
Bioinformatics; 2019 Oct; 35(20):4108-4119. PubMed ID: 30865257
[TBL] [Abstract][Full Text] [Related]
15. Prediction of drug side effects with transductive matrix co-completion.
Liang X; Fu Y; Qu L; Zhang P; Chen Y
Bioinformatics; 2023 Jan; 39(1):. PubMed ID: 36655793
[TBL] [Abstract][Full Text] [Related]
16. Drug-Drug Interaction Predicting by Neural Network Using Integrated Similarity.
Rohani N; Eslahchi C
Sci Rep; 2019 Sep; 9(1):13645. PubMed ID: 31541145
[TBL] [Abstract][Full Text] [Related]
17. Predicting lncRNA-disease associations using network topological similarity based on deep mining heterogeneous networks.
Zhang H; Liang Y; Peng C; Han S; Du W; Li Y
Math Biosci; 2019 Sep; 315():108229. PubMed ID: 31323239
[TBL] [Abstract][Full Text] [Related]
18. MARSY: a multitask deep-learning framework for prediction of drug combination synergy scores.
El Khili MR; Memon SA; Emad A
Bioinformatics; 2023 Apr; 39(4):. PubMed ID: 37021933
[TBL] [Abstract][Full Text] [Related]
19. A novel machine learning model based on sparse structure learning with adaptive graph regularization for predicting drug side effects.
Liang X; Li J; Fu Y; Qu L; Tan Y; Zhang P
J Biomed Inform; 2022 Aug; 132():104131. PubMed ID: 35840061
[TBL] [Abstract][Full Text] [Related]
20. DiSMVC: a multi-view graph collaborative learning framework for measuring disease similarity.
Wei H; Gao L; Wu S; Jiang Y; Liu B
Bioinformatics; 2024 May; 40(5):. PubMed ID: 38715444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
